 Vijaya Knight
| Title | Associate Professor |
|---|
| Institution | University of Colorado Denver - Anschutz Medical Campus |
|---|
| Department | SOM-PEDS |
|---|
|
|
|
 Bibliographic
-
Knight V, Wolf ML, Trikha A, Curran-Everett D, Hiserote M, Harbeck RJ. A comparison of specific IgE and skin prick test results to common environmental allergens using the HYTEC™ 288. J Immunol Methods. 2018 Nov; 462:9-12. PMID: 30031799.
-
Castro G, Merkel PA, Giclas HE, Gibula A, Andersen GE, Corash LM, Lin JS, Green J, Knight V, Stassinopoulos A. Amotosalen/UVA treatment inactivates T cells more effectively than the recommended gamma dose for prevention of transfusion-associated graft-versus-host disease. Transfusion. 2018 06; 58(6):1506-1515. PMID: 29607502.
-
Clark SE, Filak HC, Guthrie BS, Schmidt RL, Jamieson A, Merkel P, Knight V, Cole CM, Raulet DH, Lenz LL. Bacterial Manipulation of NK Cell Regulatory Activity Increases Susceptibility to Listeria monocytogenes Infection. PLoS Pathog. 2016 06; 12(6):e1005708. PMID: 27295349.
-
Hines SE, Barker EA, Robinson M, Knight V, Gaitens J, Sills M, Duvall K, Rose CS. Cross-Sectional Study of Respiratory Symptoms, Spirometry, and Immunologic Sensitivity in Epoxy Resin Workers. Clin Transl Sci. 2015 Dec; 8(6):722-8. PMID: 26553118; PMCID: PMC4703542 [Available on 12/01/16].
-
Merkel PA, O'Sullivan MD, Ridge C, Knight V. Critique on the quantitative nature of IgE antibody measurements. J Allergy Clin Immunol Pract. 2015 Nov-Dec; 3(6):973-5. PMID: 26143018.
-
Germinaro M, Reynolds P, Knight V, Alam R. Association of B-cell activating factor receptor deficiency with the P21R polymorphism and common variable immunodeficiency. Ann Allergy Asthma Immunol. 2015 Jul; 115(1):82-3. PMID: 26012370; PMCID: PMC4760690.
-
Honda JR, Knight V, Chan ED. Pathogenesis and risk factors for nontuberculous mycobacterial lung disease. Clin Chest Med. 2015 Mar; 36(1):1-11. PMID: 25676515.
-
Czaja CA, Merkel PA, Chan ED, Lenz LL, Wolf ML, Alam R, Frankel SK, Fischer A, Gogate S, Perez-Velez CM, Knight V. Rituximab as successful adjunct treatment in a patient with disseminated nontuberculous mycobacterial infection due to acquired anti-interferon-? autoantibody. Clin Infect Dis. 2014 Mar; 58(6):e115-8. PMID: 24336756.
-
Ovrutsky AR, Merkel PA, Schonteich E, Bai X, Kinney W, Iseman MD, Kartalija M, Knight V, Chan ED. Patients with non-tuberculous mycobacterial lung disease have elevated transforming growth factor-beta following ex vivo stimulation of blood with live Mycobacterium intracellulare. Scand J Infect Dis. 2013 Sep; 45(9):711-4. PMID: 23808720.
-
Pacheco K, Barker L, Maier L, Erb S, Sills M, Knight V. Development of a validated blood test for nickel sensitization. J Allergy Clin Immunol. 2013 Sep; 132(3):767-769. PMID: 23672782.
This graph shows the total number of publications by year, by first, middle/unknown, or last author.
To see the data from this visualization as text, click here.
| Year | Publications |
|---|
| 2013 | 3 | | 2014 | 1 | | 2015 | 3 | | 2016 | 1 | | 2018 | 2 |
To return to the timeline, click here.
|
Knight's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|